Introducing Drug Transport Early in the Design of Hypoxia Selective Anticancer Agents Using a Mathematical Modelling Approach

DOI10.1007/978-88-470-2571-4_18MaRDI QIDQ5262550zbMATH OpenOpenAlexFDO

Authors Kevin Hicks

Publication date 16 July 2015

Published in New Challenges for Cancer Systems Biomedicine (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1007/978-88-470-2571-4_18

zbMATH Keywords

drug designhypoxiapharmacokineticstumor progression

Mathematics Subject Classification ID

Biochemistry, molecular biology (92C40) Kinetics in biochemical problems (pharmacokinetics, enzyme kinetics, etc.) (92C45)

Recommendations

• Mathematical modeling and optimization of intratumor drug transport
• Mathematical modelling of the use of macrophages as vehicles for drug delivery to hypoxic tumour sites
• A mathematical model of tumor hypoxia targeting in cancer treatment and its numerical simulation
• A multi-scale analysis of drug transport and response for a multi-phase tumour model
• Mathematical modelling of drug transport in tumour multicell spheroids and monolayer cultures
• Assessing the therapeutic response of tumors to hypoxia-targeted prodrugs with an \textit{in silico} approach
• Generalized optimization of processes of drug transport in tumors
• A new mathematical model for optimizing the combination between antiangiogenic and cytotoxic drugs in oncology
• Simulation of the convective transport of cytostatic drugs in a tumor
• Multiscale modelling of fluid and drug transport in vascular tumours

Cited in

(1)

• Role of hypoxia-activated prodrugs in combination with radiation therapy: an in silico approach

This page was built for publication: Introducing Drug Transport Early in the Design of Hypoxia Selective Anticancer Agents Using a Mathematical Modelling Approach

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5262550)